The Opening Bell at Borsa İstanbul Was Rung for Orzax

Orzax successfully completed its initial public offering and began trading on Borsa Istanbul's Emerging Market under the ticker "ORZAX".

The IPO gong ceremony for Orzax, which attracted strong investor interest during the bookbuilding period, took place on 7 July Tuesday at Borsa Istanbul. The IPO, which saw participation from approximately 1 million investors, raised a total of TRY 3,622,500,000.

The IPO process for Orzax, one of Turkey's leading dietary supplement manufacturers, was conducted through capital increase and secondary offering methods, led by Info Yatırım.

"Orzax will continue its path with strong growth targets"
Speaking at the Gong Ceremony held at Borsa Istanbul, Borsa Istanbul A.Ş. Chief Executive Officer Korkmaz Ergun noted that Orzax has grown with an entrepreneurial spirit to become a strong brand.

Ergun stated that Orzax has continued its growth through R&D activities, expanding product portfolio, growing market network and export operations, emphasizing that the financing obtained from the IPO will contribute to the company's investments, increased production capacity and growth targets.

In his remarks, Ergun said: "I thank everyone who contributed to the successful IPO process, the company employees and the lead manager, and I welcome ORZAX to our Borsa family."

"Interest from approximately 1 million investors demonstrates strong potential"
Info Yatırım Deputy General Manager Hüseyin Güler noted that Orzax's IPO was the result of approximately three years of comprehensive work.

Stating that Orzax was founded in 2004 and is an established brand that has proven itself through industry leadership, strong growth performance and export capability, Güler said that the strong interest shown in the IPO is an important indicator of the company's potential and confidence in capital markets.

Güler noted that as Info Yatırım, they have contributed to the sustainable growth of companies through 29 IPOs completed in the last five years, and thanked all stakeholders involved in the process.

"We thank our investors"
Speaking at the gong ceremony, Orzax CEO Yunus Emre Alimoğlu stated that the company has been operating since 2004 with the motto "A Gift to Health".

Noting that Orzax has reached a position as a trusted brand not only in Turkey but also in different geographies through its modern production facilities, strong R&D infrastructure and broad product portfolio, Alimoğlu said the IPO is an important milestone in the company's growth journey.

Alimoğlu said: "We thank all our investors who have invested their trust in Orzax. Going forward, we are committed to creating added value for Turkey and continuing our sustainable growth."

IPO proceeds to be used for strategic investments
In his remarks on the use of funds from the IPO, Yunus Emre Alimoğlu explained that the proceeds will be allocated across three main areas.

Alimoğlu stated that the IPO proceeds will be used for financing new investments and R&D center development activities, global market growth strategies, and increasing working capital and financial efficiency.

"Through R&D and innovation, we are raising the bar in the sector"
Emphasizing that innovation and R&D are the cornerstones of Orzax, Alimoğlu noted that the company differentiates itself in the sector through its modern production facilities and high capacity.

Alimoğlu explained: "From the day we were founded, we aimed not only at growth but at adding value to human health. By seeking answers to the question 'What gift can we give to health?', we are proud to touch the lives of millions of people."

Following the IPO, Orzax aims to further strengthen its position in the health and dietary supplements sector by supporting its investments and global growth targets.